More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
Interventional Mobile C-arm and Angiography Markets Plummeted Amid COVID-19
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve...
read more
To further these efforts, Konica Minolta has partnered with 1QBit, an advanced and quantum computing software company with a strong focus on AI, based in Canada.
Sponsored Content | Blog | Artificial Intelligence | January 18, 2021
BLOG: Artificial Intelligence for Clinical Decision Support and Increased Revenues
The landscape at the Radiological Society of North America’s 2020 (RSNA20) conference was different for everyone this...
read more
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
AI Metrics Receives FDA Clearance For Imaging Software
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care...
read more
Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging

Getty Images

News | PET Imaging | January 18, 2021
Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases
January 18, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and...
read more
Coronary CT angiography images courtesy of Canon Medical Systems.

Coronary CT angiography images courtesy of Canon Medical Systems.

News | Computed Tomography (CT) | January 18, 2021
New Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque
January 18, 2020) — The Society of Cardiovascular Computed Tomography (SCCT), in collaboration with the North American...
read more
MRI of Nonferromagnetic Ballistics Suspended in Gelatin. 

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. Scout (A), T1-weighted spin-echo (SE) (B), T2-weighted SE (C), T2-weighted gradient-recalled echo (GRE) (TR/TE, 500/10; D), and T2-weighted GRE (TR/TE, 700/30; E) MR images show jacket hollow point .45 automatic Colt pistol bullet (Corbon) (1), solid lead .45 Long Colt bullet (Winchester) (2), full metal jacket (FMJ) automatic Colt pistol bullet (Winchester) (3), 5.56-mm FMJ bullet (Federal Ammunition) (4), #7 lead shotgun pellet (Winchester) (5), and 5-mm lead air gun pellet (Sheridan) (6). On all sequences, metallic artifact is minimal. Although metallic artifact increases or blooms with increased TR/TE in GRE images (D and E), amount of surrounding distortion is still minimal.

News | Magnetic Resonance Imaging (MRI) | January 15, 2021
Imaging of Ballistic Wounds, Bullet Composition and Implications for MRI Safety
January 15, 2021 — According to an article in ARRS’ American Journal of Roentgenology (AJR), because patients with...
read more
Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, announced that it has expanded its state-of-the-art multimodality medical imaging capabilities in Maryland, Virginia and Washington, DC through the acquisition of Progressive Radiology.
News | Breast Imaging | January 15, 2021
Solis Mammography Announces the Acquisition of Progressive Radiology
January 15, 2021 — Solis Mammography, the nation’s largest independent provider of breast health and diagnostic...
read more
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
Study Shows Sharp Decline in Cancer Screenings During First COVID-19 Surge
January 15, 2021 — In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses,...
read more
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the

A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant therapy shows new mass (arrow) in upper outer left breast that was assessed as BI-RADS 4. Pathologic examination from MRI-guided core biopsy of new suspicious mass revealed benign usual ductal hyperplasia. No atypia or malignancy was identified. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | MRI Breast | January 15, 2021
New Suspicious Lesions on Breast MRI in Neoadjuvant Therapy
January 15, 2021 — According to ARRS' American Journal of Roentgenology (AJR), new suspicious findings occurred in 5.5...
read more
Carestream Health showcased its expertise in medical imaging across an array of clinical specialties at the virtual meeting of the Radiological Society of North America (RSNA). From bedside imaging solutions to scalable X-ray room systems, the company demonstrated its growing product portfolio that fits budget, workflow, safety and space requirements.
News | Digital Radiography (DR) | January 14, 2021
Carestream Focused on Innovation in Diagnostic Imaging Portfolio at Virtual RSNA
January 14, 2021 — Carestream Health showcased its expertise in medical imaging across an array of clinical specialties...
read more
A targeted intervention providing mammograms to hospitalized Medicaid patients can help patients complete overdue breast cancer screening

Getty Images

News | Mammography | January 14, 2021
Inpatient Mammograms Can Reduce Disparities in Breast Cancer Screening Rates
January 14, 2021 — Completing cancer screening tests, such as mammograms, can be challenging for low-income people, who...
read more
Multidisciplinary functionality supports high-capacity utilization and economic efficiency
News | Mobile C-Arms | January 14, 2021
FDA Clears Siemens Healthineers Cios Flow Mobile C-arm System 
January 14, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Cios Flow...
read more
The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to ResearchAndMarkets.com's offering. The prostate cancer nuclear medicine diagnostics market in the US was valued at $194.47M in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach $431.76M by 2027.

Getty Images

News | Prostate Cancer | January 13, 2021
US Prostate Cancer Nuclear Medicine Diagnostics Market Outlook
January 13, 2021 — The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast...
read more
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
Use of Telehealth Jumped as Pandemic Shutdown Began
January 13, 2021 — Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with...
read more
DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content
News | Breast Density | January 13, 2021
DenseBreast-info Launches Updated Website
January 13, 2021 — DenseBreast-info.org (DB-I) invites health providers seeking the most up-to-date medically-sourced...
read more
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately
News | Mammography | January 12, 2021
Therapixel receives CE mark for AI-based software MammoScreen
January 12, 2021 — Therapixel announced that MammoScreen has successfully obtained the CE mark. After having received...
read more
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
FDA Releases AI/Machine Learning Action Plan
January 12, 2021 — The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine...
read more
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
Cardiac MRI Shows Lower Degrees of Myocarditis in Athletes Recovered from COVID-19
January 11, 2021 — In a letter published in the December issue of the American Heart Association's medical journal ...
read more
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

News | Prostate Cancer | January 11, 2021
MRI Frequently Underestimates Tumor Size in Prostate Cancer
January 11, 2021 — A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic...
read more
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
Focused Ultrasound Shows Promise for Parkinson's Disease
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson’s...
read more
© Copyright Wainscot Media. All Rights Reserved.